AR089765A1 - Un sistema para el suministro de un farmaco - Google Patents

Un sistema para el suministro de un farmaco

Info

Publication number
AR089765A1
AR089765A1 ARP130100173A ARP130100173A AR089765A1 AR 089765 A1 AR089765 A1 AR 089765A1 AR P130100173 A ARP130100173 A AR P130100173A AR P130100173 A ARP130100173 A AR P130100173A AR 089765 A1 AR089765 A1 AR 089765A1
Authority
AR
Argentina
Prior art keywords
membrane
core
intermediate layer
delivery system
active substances
Prior art date
Application number
ARP130100173A
Other languages
English (en)
Spanish (es)
Inventor
Lyytikinen Heikki
Jukarainen Harri
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR089765(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of AR089765A1 publication Critical patent/AR089765A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
ARP130100173A 2012-01-23 2013-01-21 Un sistema para el suministro de un farmaco AR089765A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23

Publications (1)

Publication Number Publication Date
AR089765A1 true AR089765A1 (es) 2014-09-17

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100173A AR089765A1 (es) 2012-01-23 2013-01-21 Un sistema para el suministro de un farmaco

Country Status (38)

Country Link
US (1) US10500381B2 (https=)
EP (1) EP2806893B1 (https=)
JP (1) JP6236401B2 (https=)
KR (1) KR102004014B1 (https=)
CN (1) CN104144702B (https=)
AR (1) AR089765A1 (https=)
AU (1) AU2013213514B2 (https=)
BR (1) BR112014017834B1 (https=)
CA (1) CA2861947A1 (https=)
CL (1) CL2014001935A1 (https=)
CO (1) CO7020911A2 (https=)
CR (1) CR20140358A (https=)
CU (1) CU24431B1 (https=)
CY (1) CY1120773T1 (https=)
DK (1) DK2806893T3 (https=)
DO (1) DOP2014000171A (https=)
EA (1) EA032208B1 (https=)
EC (1) ECSP14010605A (https=)
ES (1) ES2691635T3 (https=)
HR (1) HRP20181707T1 (https=)
IL (1) IL233599B (https=)
LT (1) LT2806893T (https=)
MX (1) MX355961B (https=)
MY (1) MY172812A (https=)
NZ (1) NZ627461A (https=)
PE (1) PE20141818A1 (https=)
PH (1) PH12014501654A1 (https=)
PL (1) PL2806893T3 (https=)
PT (1) PT2806893T (https=)
RS (1) RS57911B1 (https=)
SG (1) SG11201404032SA (https=)
SI (1) SI2806893T1 (https=)
TR (1) TR201815247T4 (https=)
TW (1) TWI626951B (https=)
UA (1) UA116197C2 (https=)
UY (1) UY34583A (https=)
WO (1) WO2013110856A1 (https=)
ZA (1) ZA201406206B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US9820994B2 (en) * 2014-06-28 2017-11-21 Laboratorios Andromaco S.A. Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth
JP2019504021A (ja) * 2015-12-21 2019-02-14 バイエル・オーイュー 膣リングを製造する方法
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
MX2020007323A (es) * 2017-09-27 2020-09-07 Bayer Oy Un metodo para modificar la liberacion de un agente terapeuticamente activo de una matriz elastomerica.
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
CN113677326A (zh) * 2019-02-19 2021-11-19 粒子科学公司 隔室化药物递送装置

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303306B1 (en) * 1987-08-08 1993-03-10 Akzo N.V. Contraceptive implant
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
WO2001085132A1 (en) 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
DE10209979A1 (de) 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US7279457B2 (en) 2004-03-12 2007-10-09 Biodel, Inc. Rapid acting drug delivery compositions
DK1629844T4 (da) 2004-07-13 2012-05-29 Bayer Schering Pharma Oy Retarderet indgivelsessystem med kontrolleret initialudbrud
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP1833469A2 (en) 2005-01-03 2007-09-19 Lupin Ltd. Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
NZ577014A (en) 2006-11-20 2011-07-29 Organon Nv Helically-shaped drug delivery system
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
EP2658524A1 (en) * 2010-12-27 2013-11-06 Dow Corning Corporation Drug delivery dispersion and film formed therefrom

Also Published As

Publication number Publication date
ZA201406206B (en) 2019-06-26
RS57911B1 (sr) 2019-01-31
CU24431B1 (es) 2019-07-04
HK1203802A1 (en) 2015-11-06
PH12014501654B1 (en) 2014-10-13
PL2806893T3 (pl) 2019-01-31
LT2806893T (lt) 2018-12-10
EA032208B1 (ru) 2019-04-30
CY1120773T1 (el) 2019-12-11
NZ627461A (en) 2016-07-29
TW201343204A (zh) 2013-11-01
TWI626951B (zh) 2018-06-21
KR20140127262A (ko) 2014-11-03
PE20141818A1 (es) 2014-12-18
WO2013110856A1 (en) 2013-08-01
DK2806893T3 (en) 2018-11-05
US10500381B2 (en) 2019-12-10
US20140350488A1 (en) 2014-11-27
BR112014017834B1 (pt) 2021-05-18
CU20140094A7 (es) 2014-11-27
PT2806893T (pt) 2018-11-09
BR112014017834A2 (https=) 2017-06-20
IL233599B (en) 2019-07-31
CO7020911A2 (es) 2014-08-11
MX2014008906A (es) 2014-08-26
ECSP14010605A (es) 2015-12-31
CA2861947A1 (en) 2013-08-01
CR20140358A (es) 2014-11-17
JP2015504083A (ja) 2015-02-05
UY34583A (es) 2013-09-02
MX355961B (es) 2018-05-07
MY172812A (en) 2019-12-12
SI2806893T1 (sl) 2019-02-28
HRP20181707T1 (hr) 2019-02-22
AU2013213514A1 (en) 2014-08-07
CN104144702B (zh) 2018-03-06
JP6236401B2 (ja) 2017-11-22
ES2691635T3 (es) 2018-11-28
EP2806893A1 (en) 2014-12-03
AU2013213514B2 (en) 2017-07-13
UA116197C2 (uk) 2018-02-26
BR112014017834A8 (pt) 2017-07-11
SG11201404032SA (en) 2014-08-28
IL233599A0 (en) 2014-08-31
DOP2014000171A (es) 2014-08-15
CL2014001935A1 (es) 2015-04-10
EA201400834A1 (ru) 2014-12-30
TR201815247T4 (tr) 2018-11-21
CN104144702A (zh) 2014-11-12
EP2806893B1 (en) 2018-07-18
KR102004014B1 (ko) 2019-07-25
PH12014501654A1 (en) 2014-10-13

Similar Documents

Publication Publication Date Title
AR089765A1 (es) Un sistema para el suministro de un farmaco
DOP2016000132A (es) Sistema de administración farmacologico
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CR20140487A (es) Peliculas de capas multiples capaces de liberar ingredientes activos por un periodo limitado de tiempo
CL2014001450A1 (es) Forma de dosis de liberacion controlada solida que comprende un analgesico opioide dispersado en un material de matriz; metodo de preparacion; uso en el tratamiento del dolor.
ECSP10010079A (es) Sistema para el suministro de una droga
MY163809A (en) Transdermal drug delivery system containing donepezil
UY31957A (es) Metodo anticonceptivo mejorado
CL2008000606A1 (es) Composicion analgesica en forma de dosificacion parenteral unitaria o en una forma de dosificacion unitaria adecuada para una administracion por la mucosa o la dermis que comprende buprenorfina y naloxona, util para el tratamiento del dolor.
MX2015012367A (es) Dispositivos de suministro de farmacos con un componente permeable al farmaco y metodos.
CL2009001556A1 (es) Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol.
DOP2010000253A (es) Sistema de administracion de drogas con efecto estabilizante
MX2016014622A (es) Sistemas de suministro de medicamentos y metodos de uso relacionados.
CL2008000608A1 (es) Composicion analgesica en forma de dosificacion parenteral unitaria o en una forma de dosificacion unitaria adecuada para una administracion por la mucosa o la dermis que comprende buprenorfina y naltrexona, util para el tratamiento del dolor.
CL2011001817A1 (es) Forma de dosificacion unitaria solida oral en forma de tableta que comprende un nucleo y un recubrimiento externo, en donde el nucleo comprende alisquireno o a una sal del mismo, y el recubrimiento en un recubrimiento de pelicula, util para el tratamiento de una enfermedad o condicion en una poblacion pediatrica.
CL2017000050A1 (es) Terapia de combinación para el cáncer
CL2013000477A1 (es) Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides.
GT201600269A (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
MX353623B (es) Sistema de suministro de farmaco.
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
ECSP10010553A (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre
CL2008000607A1 (es) Composicion analgesica en forma de dosificacion parenteral unitaria o en una forma de dosificacion unitaria adecuada para una administracion por la mucosa o la dermis que comprende buprenorfina y nalmefeno, util para el tratamiento del dolor.
CL2009000322A1 (es) Composicion farmaceutica que comprende flibanserina en su forma amorfa y al menos un excipiente, sistema farmaceutico de liberacion que comprende esta composicion, metodo para fabricar este sistema y su uso para el tratamiento de trastornos del sistema nervioso central, trastornos afectivos, trastornos del sueño y sexuales, entre otros.
PA8824601A1 (es) Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure